Tech Company Financing Transactions
Siolta Therapeutics Funding Round
Siolta Therapeutics closed a $12 million Series C venture capital round on 3/13/2024. Investors included Khosla Ventures, Symbiosis and private investors.
Transaction Overview
Company Name
Announced On
3/13/2024
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series C
Investors
Khosla Ventures (Lead Investor)
Symbiosis (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the further clinical development of it lead product, STMC-103H, and for support a collaboration with Johns Hopkins University to help select the clinical candidate to be evaluated in future trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
930 Brittan Ave.
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nikole Kimes
Chief Medical Officer
Richard Shames
Chief Scientific Officer
Ricardo Valladares
Founder
Susan Lynch
Browse more venture capital transactions:
Prev: 3/13/2024: Sugar.fit venture capital transaction
Next: 3/13/2024: IO River venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs